ChromaDex Corporation, Irvine, CA, has named William Spengler president. He will be responsible for the expansion and implementation of the company’s overall strategy. Mr. Spengler has held leadership roles in pharmaceutical companies such as Guilford Pharmaceuticals, MGI Pharma and Bristol-Myers Squibb as well as Endo Pharmaceuticals where he served as director.